Related Content
October 28, 2021 – The first patient has been treated in a new trial using stem cell therapy to treat chronic myocardial ...
June 30, 2020 — BioCardia, Inc. announced that the company has resumed cases in the CardiAMP Heart Failure Trial. The ...
October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable ...
May 16, 2019 — BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable ...
September 26, 2017 — BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial ...
September 25, 2017 — BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial ...
August 16, 2017 — BioCardia Inc. recently announced completion of treatment for the 10-patient roll-in cohort for the ...
January 9, 2017 — BioCardia Inc. announced in December the issuance of United States Patent No. 9,517,199 relating to a ...
January 3, 2017 — BioCardia Inc. announced in December the initiation of the CardiAMP Heart Failure pivotal trial, a ...
December 5, 2014 — BioCardia Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s ...